Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Hypomethylating Agent 5-Aza-2'-deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models.
Chromosomal radiosensitivity in patients with multiple sclerosis.
Astrocyte loss and astrogliosis in neuroinflammatory disorders.
Evoked potentials in multiple sclerosis.
Cerebral lesions of multiple sclerosis: is gadolinium always irreplaceable in assessing lesion activity?
Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Unmet care needs of people with a neurological chronic disease: a cross-sectional study in Italy on Multiple Sclerosis.
The Impact of Interferon Beta and Natalizumab on Comorbid Migraine in Multiple Sclerosis.
Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis.
Anti-aquaporin-4 IgG in Patients Presenting with Unilateral Optic Neuritis: A Cohort Study.
Central nervous system demyelinating disease-associated uveitis.
Induction of Heat Shock Protein 70 (Hsp70) prevents neuregulin-induced demyelination by enhancing the proteasomal clearance of c-Jun.
Clinical utility of glatiramer acetate in the management of relapse frequency in multiple sclerosis.
Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review.
Intracellular signaling pathway regulation of myelination and remyelination in the CNS.
Alleviation of experimental allergic encephalomyelitis in C57BL/6 mice by soy daidzein.
Drug therapy for multiple sclerosis.
Erratum to: Genomic Binding Sites and Biological Effects of the Vitamin D-VDR Complex in Multiple Sclerosis.
Monomethylfumarate reduces in vitro migration of mononuclear cells.
Supporting work for people with multiple sclerosis.
Cognitive impairment among different clinical courses of multiple sclerosis.
Epithelial v-like antigen mediates efficacy of anti-alpha4 integrin treatment in a mouse model of multiple sclerosis.
Impact of simulated microgravity on oligodendrocyte development: implications for central nervous system repair.
c-kit plays a critical role in induction of intravenous tolerance in experimental autoimmune encephalomyelitis.
Teriflunomide for oral therapy in multiple sclerosis.
Pages
« first
‹ previous
…
280
281
282
283
284
285
286
287
288
…
next ›
last »